shutterstock_1985962832_marco-lazzarini
shutterstock_1985962832_Marco Lazzarini
28 July 2022Big PharmaStaff Writer

Vaccine makers hit back against patent claims

German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
14 July 2022   New lawsuit comes months after the pair were accused of infringing lipid nanoparticle technology.
Medtech
2 August 2022   Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.
Big Pharma
2 February 2023   Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.

More on this story

Americas
14 July 2022   New lawsuit comes months after the pair were accused of infringing lipid nanoparticle technology.
Medtech
2 August 2022   Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.
Big Pharma
2 February 2023   Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.

More on this story

Americas
14 July 2022   New lawsuit comes months after the pair were accused of infringing lipid nanoparticle technology.
Medtech
2 August 2022   Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.
Big Pharma
2 February 2023   Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.